tiprankstipranks
Trending News
More News >
Innovative Pharmaceutical Biotech Limited (HK:0399)
:0399
Hong Kong Market

Innovative Pharmaceutical Biotech (0399) Income Statement

Compare
0 Followers

Innovative Pharmaceutical Biotech Income Statement

Last quarter (Q4 2024), Innovative Pharmaceutical Biotech's total revenue was HK$-938.00K, a decrease of -123.83% from the same quarter last year. In Q4, Innovative Pharmaceutical Biotech's net income was HK$-447.68M. See Innovative Pharmaceutical Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
HK$ 2.09MHK$ 6.59MHK$ 8.07MHK$ 11.14MHK$ 15.19M
Gross Profit
HK$ 188.00KHK$ 840.00KHK$ 858.00KHK$ 1.05MHK$ 1.41M
Operating Expenses
HK$ 13.45MHK$ 14.27MHK$ 21.56MHK$ 25.49MHK$ 22.79M
Depreciation and Amortization
HK$ 0.00HK$ 941.00KHK$ 1.88MHK$ 2.13MHK$ 2.31M
EBITDA
HK$ -310.25MHK$ 317.75MHK$ -18.82MHK$ 228.51MHK$ -18.81M
Operating Income
HK$ -13.26MHK$ -13.43MHK$ -20.70MHK$ -24.35MHK$ -21.34M
Other Income/Expenses
HK$ -557.08MHK$ 112.14MHK$ -233.97MHK$ 60.78MHK$ -190.77M
Pretax Income
HK$ -570.35MHK$ 98.71MHK$ -254.67MHK$ 36.43MHK$ -212.16M
Net Income
HK$ -345.94MHK$ 103.40MHK$ -245.70MHK$ 296.54MHK$ -395.75M
Per Share Metrics
Basic EPS
HK$ -0.20HK$ 0.07HK$ -0.17HK$ 0.20HK$ -0.27
Diluted EPS
HK$ -0.20HK$ -0.01HK$ -0.17HK$ 0.17HK$ -0.27
Weighted Average Shares Outstanding
1.73B 1.53B 1.46B 1.46B 1.46B
Weighted Average Shares Outstanding (Diluted)
1.73B 2.50B 1.46B 1.75B 1.46B
Currency in HKD

Innovative Pharmaceutical Biotech Earnings and Revenue History